Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04332757
Other study ID # 349408
Secondary ID ASC/BA/00665
Status Recruiting
Phase N/A
First received
Last updated
Start date July 4, 2019
Est. completion date September 20, 2022

Study information

Verified date May 2021
Source Nottingham Trent University
Contact Craig Sale, PhD
Phone +44(0)115 848 3505
Email craig.sale@ntu.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to investigate the effectiveness of a personalised physical training programme in returning servicewomen to fitness following childbirth. The idea behind the program is to target core and pelvic floor muscles, along with whole body strength and endurance to help servicewomen return to work safely and in a physically fit condition. The study will monitor the response to training using the following measures: urogynaecological measures (e.g., pelvic floor strength, prolapse, urinary incontinence), military specific fitness tests, musculoskeletal health (e.g., muscle and bone mass & function) and mental health and wellbeing.


Description:

In an independent groups study design, the aim was to investigate the efficacy of a postpartum physical development programme on core reconnection (i.e., pelvic floor function, core strength/stability and urogynaecological measures), occupational physical performance, musculoskeletal health, and psychological health/wellbeing in servicewomen. Given that policy guidance is urgently needed regarding the safe return of servicewomen to functional occupational fitness, the aim of our proposed research is to inform the appropriate physical preparation of servicewomen in the postpartum period. Participants at selected sites around the Royal Military Academy at Sandhurst will receive usual care/no formal intervention (acting as a control group [CON]) and participants at different sites around Army Headquarters will receive usual care and additionally complete an 18-week phased physical development (rehabilitation and training) programme between weeks 6 and 24 postpartum (acting as the intervention group [INT]). If recruitment numbers are low at the main sites (Aldershot and Tidworth) we will seek to recruit participants to INT from Bulford, Middle Wallop, Larkhill and Marlborough Lines for INT and to CON from Sandhurst, Odiham, Pirbright, Keogh, Minley, Deepcut as well as locations outside of the named INT sites. The geographical separation of sites was deemed to be important for maintaining differences between intervention and control group activity. The investigators have designed a phased 18-week physical development programme to train both rehabilitative and performance enhancement elements of physical preparation. The rehabilitation element of the programme will specifically target pelvic floor function and core strength and stability (known collectively as Core Reconnection training) from weeks 6 to 24 postpartum, and the training element of the programme will contain resistance and high-intensity interval training (HIIT) from weeks 12 to 24 postpartum The aim of this research is to investigate the effectiveness of a tailored rehabilitation and physical preparation programme for postpartum women on: 1. Occupational fitness performance; 2. Female health assessments (i.e., urinary incontinence, pelvic floor strength); 3. Musculoskeletal health; 4. Psychological health and wellbeing.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date September 20, 2022
Est. primary completion date September 20, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Serving, pregnant (third trimester) or 0 to 6 weeks postpartum UK MOD Servicewomen. 2. = 18 years old. 3. Free from any condition or injury that may affect the individual's ability to perform exercise (health screen). 4. Passed fit to exercise by their GP at their routine 6-week postnatal check-up 5. Passed fit to participate by a specialist women's health physiotherapist using study specific assessment criteria. 6. Consent to be pregnancy tested before scans at 6 and 24 weeks postpartum. Exclusion Criteria: 1. < 18 years old 2. Diagnosed with post-natal depression or another mental health condition requiring specialist psychiatric secondary care. Additionally, any participant who is found to have, or develops over the course of the trial, severe post-natal depression or suicidal tendencies, will be referred back to their GP. 3. Injured or suffering from another condition that can affect the individual's ability to perform exercise. 4. Not passed fit to exercise by their GP at their routine 6-week postnatal check [using standard fitness assessment criteria]. 5. Not passed fit to participate following the women's clinical health assessment [using study specific assessment criteria]. 6. Women who report that they could be pregnant and / or have a positive pregnancy test before measurements at 6 and 24 weeks postpartum will not be scanned using DXA or HR-pQCT. They will cease to take any further part in the trial and will be advised to visit their GP.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Training intervention.
The investigators have designed a phased 18-week physical development programme to train both rehabilitative and performance enhancement elements of physical preparation. The rehabilitation element of the programme will specifically target pelvic floor function and core strength and stability (known collectively as Core Reconnection training) from weeks 6 to 24 postpartum, and the training element of the programme will contain resistance and high-intensity interval training (HIIT) from weeks 12 to 24 postpartum.

Locations

Country Name City State
United Kingdom Keogh Barracks Aldershot Hampshire
United Kingdom Aldershot Centre for Health, Aldershot, Hampshire,
United Kingdom Minley Medical Centre Blackwater Surrey
United Kingdom MRS Royal Military Academy Camberley, Surrey,
United Kingdom The Princess Royal Barracks Deepcut Surrey
United Kingdom Station Medical Centre Hook Hampshire
United Kingdom Elizabeth Barracks Pirbright Surrey
United Kingdom Bulford Medical Centre Salisbury Wiltshire
United Kingdom Larkhill Medical Centre Salisbury, Wiltshire
United Kingdom Middle Wallop Medical Centre, Stockbridge, Hampshire
United Kingdom Queen Elizabeth Memorial Health Centre Tidworth Wiltshire

Sponsors (6)

Lead Sponsor Collaborator
Nottingham Trent University Clare Pacey Physiotherapy Limited, Ministry of Defence, United Kingdom, Robert Gordon University, University of Nottingham, University of Stirling

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical Performance Change Between 12 and 24 Weeks Postpartum Physical performance will be measured at weeks 12 and 24 using elements of the Soldier Strength and Conditioning review , which the servicewomen need to complete as part of their return to service following maternity leave. These tests include a vertical jump, mid-thigh pull, seated medicine ball throw and a 2 km run to best effort. Physical performance will be measured at weeks 12 and 24 postpartum.
Secondary Pelvic Organ Prolapse- Quantification System Change in Scores Between 6, 12 and 24 Weeks Postpartum Pelvic Organ Prolapse will be measured by the research associate women's health physiotherapist at weeks 6, 12 and 24. Vaginal examination will assess for prolapse using the Pelvic Organ Prolapse Quantification system staging pelvic support from 0-4, 0 being no prolapse demonstrated and 4 demonstrating full procidentia. : Pelvic Organ Prolapse- Quantification will be measured at weeks 6, 12 and 24 postpartum.
Secondary Pelvic Floor Strength Change in Scores Between 6,12 and 24 Weeks Postpartum Pelvic floor strength will be measured by the research associate women's health physiotherapist at week 6, 12 and 24. Pelvic floor strength will be measured digitally using the modified oxford scale ranging from 0-5, 0 being no discernible contraction and 5 overcoming strong resistance. Over-activity and co-ordination of the pelvic floor muscle will be assessed by a simple yes/no answer following digital vaginal examination. Pelvic floor distress inventory questionnaire will be measured at weeks 6, 12 and 24 postpartum.
Secondary Musculoskeletal Physiotherapy Assessment Change Between 6,12 and 24 Weeks Postpartum Musculoskeletal physiotherapy measures will be assessed by the research associate women's health physiotherapist at weeks 6, 12 and 24. Posture, movement patterns, breathing will be objectively evaluated and commented on. The abdominal muscles (rectus diastasis) will be assessed by measuring the distance between the internal borders of the rectus abdominus muscle by placing the fingers vertically on the linea alba 4 cm above and below the umbilicus, during a curl up movement. Scoring is obtained through an approximation of centimetre width separation and the tone of the linea alba structure. The larger the score in centimetres the greater the separation of the rectus abdominus muscle. : Musculoskeletal physiotherapy assessment will be measured at weeks 6, 12 and 24 postpartum.
Secondary Pelvic Floor Distress Inventory Questionnaire, Change in Scores Between 6, 12 and 24 Weeks Postpartum The Pelvic Floor Distress Inventory will be completed at 6, 12 and 24 weeks by all participants. The Pelvic Floor Distress Inventory is scored ranging from 0-300, 0 being the least distress and 300 being the greatest distress. Pelvic floor distress inventory questionnaire will be measured at weeks 6, 12 and 24 postpartum.
Secondary International Consultation on Incontinence Questionnaire - Vaginal Symptoms, Change in Scores Between 6, 12 and 24 Weeks Postpartum The International Consultation on Incontinence Questionnaire - Vaginal Symptoms will be completed at 6, 12 and 24 weeks by all participants. The International consultation on Incontinence Questionnaire - Vaginal Symptoms evaluates vaginal symptoms, associated sexual matters and impact on quality of life. Three scores are generated. Subscales range from 0-53 vaginal symptoms, 0-58 sexual matters and 0-10 overall impact on quality of life. 0 represents the least bothersome in each subscale. The subscales are not incorporated in an overall score. International consultation on incontinence questionnaire - vaginal symptoms will be measured at weeks 6, 12 and 24 postpartum.
Secondary World Health Organisation Quality of Life Questionnaire, Change in Scores Between 6, 12 and 24 Weeks Postpartum The World Health Organisation Quality of Life Questionnaire (WHOQOL-BREF) will be given to participants in paper. The WHOQOL-BREF provides an overall quality of life/wellbeing score and allows calculation of a score for each of the four sub-scales (physical health, psychological, social relationships and environment). The four domain scores are scaled in a positive direction (higher score equal higher quality of life). The mean score of items within each domain is used to calculate the domain score. The World Health Organisation Quality of Life Questionnaire will be measured at weeks 6, 12 and 24 postpartum.
Secondary Edinburgh Post Natal Depression Scale, Change in Scores Between 6, 12 and 24 Weeks Postpartum The Edinburgh Post Natal Depression Scale (EPDS) asks participants to answer questions by reflecting on the past 7 days. The questionnaire produces a total score of postnatal depression symptoms (range 0-30) with a score of 13 and above indicating likelihood of a depressive illness of varying severity The Edinburgh Post Natal Depression Scale will be measured at weeks 6, 12 and 24 postpartum.
Secondary Body Composition Changes Between 6 and 24 Weeks Postpartum Body composition (fat mass, fat-free mass and bone mineral density) will be measured at weeks 6 and 24 by a whole-body dual-energy x-ray absorptiometry (DXA) scan. Body composition will be measured at weeks 6 and 24 postpartum.
Secondary Bone Health Changes Between 6 and 24 Weeks Postpartum Bone microarchitecture will be determined at weeks 6 and 24 by a HRpQCT scan; two scans of the tibia (distal 4% and 30% site) will be performed on the non-dominant leg to assess training-induced changes in bone microarchitecture and density. Bone health will be measured at weeks 6 and 24 postpartum.
Secondary Tendon Properties Changes Between 6, 12 and 24 Weeks Postpartum Tendon stiffness and young's modulus will be measured using ultrasonography with a linear array probe. Patella tendon length and elongation will be calculated as the distance from the apex of the patellar and the shadow created by a fixed marker. Patella tendon stiffness will be calculated by dividing knee extensor torque by the estimated patella tendon moment arm. Knee extensor torque will be calculated as the sum of the measured knee extension torque and the antagonistic torque, estimated through the root mean square of the biceps femoris muscle electromyography signal. Force-elongation data will be fitted with to a second order polynomial curve to determine patella tendon stiffness. Tendon CSA will be assessed along the full resting length of the tendon on the axial plane through ultrasonography. Young's modulus will then be calculated as tendon stiffness multiplied by the ratio of tendon length over tendon cross-sectional area. Tendon properties will be measured at weeks 6, 12 and 24 postpartum.
Secondary Muscle Architecture Changes Between 6, 12 and 24 Weeks Postpartum Fascicle length of the vastus lateralis will be assessed at weeks 6, 12 and 24 by the acquisition and analysis of images taken using B-mode ultrasonography (MyLab Omega, Esaote, UK), with a linear array probe. Images will be obtained with the participant lying at rest in a supine position. Images will be taken at 50% of the length of the vastus lateralis and at the midsagittal line of the muscle. The transducer will be aligned to the fascicle plane to allow optimal capture of the fascicles. Muscle architecture will be measured at weeks 6, 12 and 24 postpartum.
Secondary Muscle Protein and Collagen Turnover Changes Between 12 and 18 Weeks Postpartum Muscle protein/collagen turnover will be measured from blood, saliva and skeletal muscle biopsy samples. Participants will provide a saliva sample before being given a drink of 'heavy' water (D2O); water that is enriched with a metabolic isotope tracer that can be used to evaluate the rate of protein and collagen turnover by determining the rate of tracer incorporation into muscle tissue. The muscle biopsy will be used to measure the incorporation of deuterated alanine into muscle tissue over time and enable the calculation of the fractional rate of muscle protein synthesis by mass spectrometry. : Muscle protein and collagen turnover will be measured at weeks 12 and 18 postpartum.
Secondary Muscle Mass Changes Between 6, 12, 18 and 24 Weeks Postpartum We intend to estimate whole-body muscle mass using D3-Creatine (D3-Cr), measured in urine at weeks 6, 12, 18 and 24 postpartum. Using a creatine-tracer measure of muscle mass, Urine D3-creatine and D3-creatinine and unlabelled creatine and creatinine will be measured by liquid chromatography/mass spectrometry, which will allow the calculation of total body creatine pool size and muscle mass. Muscle mass will be measured at weeks 6, 12,18 and 24 postpartum.
Secondary Muscle Breakdown Changes Between 12 and 18 Weeks Postpartum We intend to estimate muscle breakdown using D3-3-methylhistidine (D3-3MH), measured in urine at weeks 12 and 18 postpartum. Isotopic enrichment of D3-3MH in urine will be measured by gas chromatography/mass spectrometry, which will allow the calculation of muscle protein breakdown. Muscle breakdown will be measured at weeks 12 and 18 postpartum
See also
  Status Clinical Trial Phase
Completed NCT00001867 - Effect of Pregnancy on Uveitis N/A
Active, not recruiting NCT03703804 - AfterBabyBodyStudy- Testing Manual Examination Methods and Exercise Effects on Muscular Recovery After Pregnancy
Completed NCT04153760 - Pilot PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity Early Phase 1
Completed NCT03004872 - Relationship Between Postpartum Mood Disorders and Delivery Experience
Completed NCT01272960 - Mirena Intrauterine System Timing of Insertion: A Randomized Controlled Trial N/A
Completed NCT00563264 - KAN-DO: A Family-based Intervention to Prevent Childhood Obesity N/A
Active, not recruiting NCT05510284 - Post-partum Care in the NICU N/A
Completed NCT04238117 - Laser Acupuncture Therapy in Postpartum Low Back Pain N/A
Completed NCT04977713 - Delivery Pain and Postpartum Comfort N/A
Completed NCT04389489 - Postpartum Sexual Function in Pregnant Women With COVID-19
Completed NCT04783324 - The Effect of the E-Mobile Health Application on Postpartum Adaptation N/A
Completed NCT01020240 - Physiotherapy in Postpartum After a Cesarean N/A
Completed NCT03436888 - Cross-cultural Adaptation and Validation of the Pelvic Girdle Questionnaire in French Language
Active, not recruiting NCT05674461 - The Effect of WhatsApp-Based and Face-to-face Nursing Education on Mothers' Quality of Life and Traditional Practices N/A
Recruiting NCT05188963 - RCT About Two Different Regimens of Clean Intermittent Catheterization in Women With Overt Postpartum Urinary Retention N/A
Completed NCT00998595 - Gestational Diabetes Follow Up Study N/A
Enrolling by invitation NCT06119282 - The Effect of Aromatherapy in Women With Primiparous Cesarean Section N/A
Completed NCT02781714 - Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya N/A
Completed NCT00828542 - Safety of the Etonogestrel-Releasing Implant During the Puerperium of Healthy Women N/A
Completed NCT05439668 - Comparison of Two Abdominal Exercise Programs on the Interrect Distance N/A